(Q28238938)
Statements
Farnesyltransferase inhibitor tipifarnib is well tolerated, induces stabilization of disease, and inhibits farnesylation and oncogenic/tumor survival pathways in patients with advanced multiple myeloma (English)
Melissa Alsina
Edward F Wilson
A Nelida Belle
Elvira Gerbino
Tammy Price-Troska
Rose M Overton
Gregory Ahmann
Laura M Bruzek
John J Wright
Daniel Sullivan
Alan B Cantor
Philip R Greipp
William S Dalton
Saïd M Sebti
Benjamin Djulbegovic
15 January 2004